MicroRNAs - Biogênese, funções e características moleculares do glioblastoma

MicroRNAs - Biogênese, funções e características moleculares do glioblastoma

A identificação de biomarcadores prognósticos e preditivos poderá personalizar a terapia antineoplásica com vistas a uma maior sobrevida, redução da recidiva e melhor qualidade de vida aos pacientes com diagnóstico de glioblastoma. Temos atualmente diversos candidatos a potenciais biomarcadores que...

Full description

Saved in:

Bibliographic Details
Main Authors:	Felipe Amstalden Trevisan, Harley Francisco de Oliveira, Daniela Pretti da Cunha Tirapelli, Carlos Gilberto Carlotti Junior
Format:	Article
Language:	English
Published:	Thieme Revinter Publicações Ltda. 2017-01-01
Series:	Brazilian Journal of Oncology
Subjects:	Glioblastoma MicroRNAs Radioterapia MGMT Mutação IDH-1 Radiotherapy IDH-1 mutation
Online Access:	http://www.thieme-connect.de/DOI/DOI?10.1055/s-0044-1792181
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

IDH mutation and MGMT methylation status in glioblastoma and other gliomas patients: a Russian retrospective cohort study
by: Moez Eid, et al.
Published: (2025-05-01)

MORPHOLOGIC AND MOLECULAR FEATURES OF PRIMARY GLIOBLASTOMA IN PATIENTS SURVIVING MORE THAN 3 YEARS
by: M. V. Matsko, et al.
Published: (2019-06-01)

CHANGES IN THE MGMT GENE EXPRESSION IN PATIENTS WITH PRIMARY GLIOBLASTOMA AFTER RELAPSE. INFLUENCE OF CLINICAL CHARACTERISTICS AND MGMT EXPRESSION ON SURVIVAL OF PATIENTS
by: M. V. Matsko, et al.
Published: (2021-06-01)

Isocitrate dehydrogenase 1 and 2 genes mutations and MGMT methylation in gliomas
by: D. V. Tabakov, et al.
Published: (2017-04-01)

Predictive role of MGMT and IDH status in the efficacy of bevacizumab for high-grade glioma: a retrospective study
by: Bai Xuexue, et al.
Published: (2025-08-01)

Genetic Profile of Primary Brain Tumours and the Degree of Their Resection Versus Survival of Patients Undergoing Surgery and Complementary Oncological Treatment
by: Lech Grzelak, et al.
Published: (2022-12-01)

Biomolecular Predictors of Recurrence Patterns and Survival in IDH-Wild-Type Glioblastoma: A Retrospective Analysis of Patients Treated with Radiotherapy and Temozolomide
by: Paolo Tini, et al.
Published: (2025-07-01)

Multipool-CEST and CEST-based pH assessment as predictive tools for glioma grading, IDH mutation, 1p/19q codeletion, and MGMT promoter methylation in gliomas
by: Xinli Zhang, et al.
Published: (2024-12-01)

The TERT promoter mutation status and MGMT promoter methylation status, combined with dichotomized MRI‐derived and clinical features, predict adult primary glioblastoma survival
by: Chang Shu, et al.
Published: (2018-08-01)

Features of epileptiform activity in patients with diagnosed glioblastoma: from genetic and biochemical mechanisms to clinical aspects
by: E. E. Tyagunova, et al.
Published: (2022-12-01)

Analysis of Caspase-9 protein and microRNAs miR-21, miR-126 and miR-155 related to the apoptosis mechanism in the cerebellum of rats submitted to focal cerebral ischemia associated with an alcoholism model
by: Jairo Pinheiro da SILVA, et al.
Published: (2019-10-01)

Expression of NMDA receptor and microRNA-219 in rats submitted to cerebral ischemia associated with alcoholism
by: Cristiane Iozzi Silva, et al.

A multitask framework based on CA-EfficientNetV2 for the prediction of glioma molecular biomarkers
by: Qian Xu, et al.
Published: (2025-07-01)

The relationship between IDH, P53 mutations, MGMT methylation with characteristics in high grade glioma patients
by: Duc Anh Tran, et al.
Published: (2022-07-01)

“Comprehensive Analysis of Factors Influencing Recurrence and Survival in Glioblastoma: Implications for Treatment Strategies”: A Single Center Study
by: Ahmed Bendari, et al.
Published: (2024-11-01)

Siramesine induced cell death of glioblastoma through inactivating the STAT3-MGMT signaling pathway
by: Xiaohang Cui, et al.
Published: (2025-07-01)

MicroRNAs and type 2 diabetes
by: Jiali Deng, et al.
Published: (2019-06-01)

Sequence Analysis of microRNAs Encoded by Simian Lymphocryptoviruses
by: Yan Chen, et al.
Published: (2024-12-01)

Identification of Specific microRNAs in Adipose Tissue Affected by Lipedema
by: Erika Cione, et al.
Published: (2024-10-01)

MicroRNAs involved in colorectal cancer, a rapid mini-systematic review
by: Sogol Shirzad, et al.
Published: (2025-05-01)

Similar overall survival with reduced vs. standard dose bevacizumab monotherapy in progressive glioblastoma
by: Jack Patrick Gleeson, et al.
Published: (2020-01-01)

The impact of the subventricular zone invasion types and MGMT methylation status on tumor recurrence and prognosis in glioblastoma
by: Zhiying Shao, et al.
Published: (2024-12-01)

MGMT epimutations and risk of incident cancer of the colon, glioblastoma multiforme, and diffuse large B cell lymphomas
by: Oleksii Nikolaienko, et al.
Published: (2025-02-01)

Temozolomide-based radio-chemotherapy for newly diagnosed pediatric high-grade gliomas (HIT-HGG-2007): A prospective, multicenter, single-arm, phase II trial
by: Michael Karremann, et al.
Published: (2025-12-01)

Circulating microRNA profiles in early-stage osteoarthritis and rheumatoid arthritis
by: Madhu Baghel, et al.
Published: (2025-07-01)

Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy
by: Shigeo Ohba, et al.
Published: (2025-01-01)

IDH1 Mutation Impacts DNA Repair Through ALKBH2 Rendering Glioblastoma Cells Sensitive to Artesunate
by: Olivier Switzeny, et al.
Published: (2025-06-01)

MicroRNA expression and GPX-1 genetic polymorphisms in patients undergoing hemodialysis: Implications for oxidative stress in a cross-sectional study
by: Hetaf Shallal, et al.
Published: (2025-02-01)

Temporal Muscle Thickness as a Prognostic Marker in a Real‐Life Cohort of Newly Diagnosed MGMT Promoter Methylated Glioblastoma: A Multicentric Imaging Analysis
by: Lazaros Lazaridis, et al.
Published: (2025-04-01)

miRNA interplay: Mechanisms and therapeutic interventions in cancer
by: Zehua Wang, et al.
Published: (2024-12-01)

Molecular Biomarkers of Glioma
by: Punsasi Rajakaruna, et al.
Published: (2025-05-01)

MicroRNAs in anthracycline cardiotoxicity: biomarkers, mechanisms, and therapeutic advances
by: Hongyun Mao, et al.
Published: (2025-08-01)

Association of plasma microRNAs with COVID-19 severity and outcome
by: Sohair Salem, et al.
Published: (2024-12-01)

Changes in microRNA expression associated with preeclampsia: a systematic review
by: A.C.S. Lopes, et al.
Published: (2025-05-01)

MicroRNAs modulation by isodrimeninol from Drimys winteri in periodontitis-associated cellular models: preliminary results
by: Nelia M. Rodríguez, et al.
Published: (2025-05-01)

Intestinal accumulation of microbiota-produced succinate caused by loss of microRNAs leads to diarrhea in weanling piglets
by: Xihong Zhou, et al.
Published: (2022-12-01)

Identification of inflammation-related genes signature to establish a prognostic model in MGMT unmethylated glioblastoma patients
by: Yunzhao Mo, et al.
Published: (2025-02-01)

Prediction of MGMT methylation status in glioblastoma patients based on radiomics feature extracted from intratumoral and peritumoral MRI imaging
by: Wang-Sheng Chen, et al.
Published: (2025-07-01)

Circulating microRNA profiles are associated with acute pain and stress in castrated and tail docked lambs
by: Ryan J. Farr, et al.
Published: (2025-06-01)

The emerging role of miRNAs in biological aging and age-related diseases
by: Rawad Turko, et al.
Published: (2025-08-01)